 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 12/01/2025 |
$43.85 |
$44.11 |
$43.33 |
$43.43 |
2.48M | | 12/02/2025 |
$43.77 |
$43.98 |
$43.00 |
$43.44 |
2.24M | | 12/03/2025 |
$43.57 |
$44.48 |
$43.47 |
$44.01 |
2.73M | | 12/04/2025 |
$43.97 |
$44.79 |
$43.95 |
$44.37 |
2.06M | | 12/05/2025 |
$44.20 |
$44.59 |
$43.85 |
$44.36 |
2.19M |
|
|
| Exelixis, Inc. is an oncology company. Co. is engaged in developing medicines and combination regimens at the forefront of cancer care. It has produced four marketed pharmaceutical products, two of which are formulations of its flagship molecule, cabozantinib. Cabozantinib is an inhibitor of multiple tyrosine kinases, including MET, AXL, VEGF receptors and RET and has been also approved as CABOMETYX tablets for advanced renal cell carcinoma (RCC), for previously treated hepatocellular carcinoma (HCC) and for previously treated, radioactive iodine (RAI)-refractory differentiated thyroid cancer (DTC), and as COMETRIQ capsules for progressive, metastatic medullary thyroid cancer (MTC). | |
|
Exelixis (EXEL) has the following price history information. Looking back at EXEL historical stock prices for the last five trading days, on December 01, 2025, EXEL opened at $43.85, traded as high as $44.11 and as low as $43.33, and closed at $43.43. Trading volume was a total of 2.48M shares. On December 02, 2025, EXEL opened at $43.77, traded as high as $43.98 and as low as $43.00, and closed at $43.44. Trading volume was a total of 2.24M shares. On December 03, 2025, EXEL opened at $43.57, traded as high as $44.48 and as low as $43.47, and closed at $44.01. Trading volume was a total of 2.73M shares. On December 04, 2025, EXEL opened at $43.97, traded as high as $44.79 and as low as $43.95, and closed at $44.37. Trading volume was a total of 2.06M shares. On December 05, 2025, EXEL opened at $44.20, traded as high as $44.59 and as low as $43.85, and closed at $44.36. Trading volume was a total of 2.19M shares.
EXEL Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Exelixis shares, starting with a $10,000 purchase of EXEL, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
12/09/2015 |
|
| End date: |
12/05/2025 |
|
| Start price/share: |
$4.81 |
|
| End price/share: |
$44.36 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
822.25% |
|
| Average Annual Total Return: |
24.89% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$92,259.73 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 12/01/2025 | $43.43 | | 12/02/2025 | $43.44 | | 12/03/2025 | $44.01 | | 12/04/2025 | $44.37 | | 12/05/2025 | $44.36 |
|
|
Free EXEL Email Alerts:
